CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Imbruvica-Venclexta Combination Demonstrates Benefits in Untreated CLL

December 4th 2023, 4:00pm

Article

Results from a four-year follow-up of a phase 3 trial determined that the combination of Imbruvica and Venclexta provided benefits for untreated patients with CLL.

FDA Approves Jaypirca for Pretreated CLL, SLL

December 2nd 2023, 12:22am

Article

The Food and Drug Administration approved Jaypirca for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who received two or more lines of therapy.

FDA Accepts Priority Review for Breyanzi in CLL

November 17th 2023, 8:00am

Article

The Food and Drug Administration accepted a Priority Review for Breyanzi for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL).

CLL and Its Treatment Can Heighten Patients’ Risk of Infections

November 8th 2023, 2:00pm

Article

Patients with chronic lymphocytic leukemia are at risk for an increased number and severity of infections due to both their disease and its treatment, an expert explained during the CURE® Educated Patient® CLL Summit.

Targeted Agents Shift the Landscape of CLL Treatment

November 6th 2023, 10:00pm

Article

Recent years have brought more targeted agents to the frontline treatment for patients with chronic lymphocytic leukemia.

Patients With CLL Could Also Face Autoimmune Complications, Expert Says

October 31st 2023, 2:16pm

Article

Autoimmune diseases in patients with CLL are separate from CLL, which calls for different treatments.

After Cancer, I’m More Vigilant About Health Risks

October 19th 2023, 1:00pm

Article

After receiving two cancer diagnoses, I became more vigilant about my health — especially during the COVID-19 pandemic.

Calquence Had Fewer Heart Complications Than Imbruvica in CLL Treatment

October 13th 2023, 10:00pm

Article

Fewer patients with chronic lymphocytic leukemia experienced cardiac toxicities with Calquence than those treated with Imbruvica, research showed.

If You Have To Have Cancer

October 13th 2023, 5:00pm

Article

Never underestimate your value to a person who has just been diagnosed. Isn’t that what these blogs are all about anyway?

Chronic Lymphocytic Leukemia Headlines from 2023

September 28th 2023, 8:58pm

Article

CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023.